Top Back to top

Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP)

Infectious Diseases Working Party (IDWP)
Transplant Complications Working Party (TCWP)
Study number:
Type of transplant:
Short title:
CNS Study
Study status:
Deadline for data collection:
Study design:
Non-interventional prospective study
Primary objective:
- Clinical and diagnostic characteristics of infectious and non-infectious CNS disorders following allogeneic or autologous HSCT
- Outcome 30 days after CNS disorder onset (cured vs. improved vs. stabilized vs. worsened vs. died due to CNS disorder vs. died by other cause)
Key inclusion criteria:
All patients who undergo allogeneic or autologous HSCT between January 1st, 2021 and December 31st, 2022 and develop an infectious (any CTCAE grade) or relevant (CTCAE >1°) non-infectious CNS disorder after HSCT in this period
Principal investigator:
Martin Schmidt-Hieber
Principal investigator email:
EBMT Study coordinator:
Nina Knelange
Study coordinator email: